Lungs in Vitro Model Market, Global Outlook and Forecast 2022-2028

March 2022 | 68 pages | ID: L7A8D9E119B1EN
Market Monitor Global

Abstracts

Lungs in Vitro is applied for Drug Screening, Toxicology, 3D Model Development, Basic Research, Physiologic Research, Stem Cell Research, and Regenerative Medicine. It include four types that are 2D Cell Models, 3D Cell Models, Commercial 3D Cell Models, and Inhouse 3D Cell Models

This report contains market size and forecasts of Lungs in Vitro Model in Global, including the following market information:

Global Lungs in Vitro Model Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Lungs in Vitro Model market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

2D Cell Models Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Lungs in Vitro Model include ATCC, Lonza, Epithelix, Mattek, Emulate, Mimetas, Tissuse, Insphero and Cn Bio, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Lungs in Vitro Model companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Lungs in Vitro Model Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Lungs in Vitro Model Market Segment Percentages, by Type, 2021 (%)

• 2D Cell Models
• 3D Cell Models

Global Lungs in Vitro Model Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Lungs in Vitro Model Market Segment Percentages, by Application, 2021 (%)

• Drug Discovery and Toxicology
• 3D Model Development
• Basic Research
• Physiological Research
• Stem Cell Research and Regenerative Medicine

Global Lungs in Vitro Model Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Lungs in Vitro Model Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Lungs in Vitro Model revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Lungs in Vitro Model revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• ATCC
• Lonza
• Epithelix
• Mattek
• Emulate
• Mimetas
• Tissuse
• Insphero
• Cn Bio
• AlveoliX
• Oncotheis

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Lungs in Vitro Model Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Lungs in Vitro Model Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL LUNGS IN VITRO MODEL OVERALL MARKET SIZE

2.1 Global Lungs in Vitro Model Market Size: 2021 VS 2028
2.2 Global Lungs in Vitro Model Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Lungs in Vitro Model Players in Global Market
3.2 Top Global Lungs in Vitro Model Companies Ranked by Revenue
3.3 Global Lungs in Vitro Model Revenue by Companies
3.4 Top 3 and Top 5 Lungs in Vitro Model Companies in Global Market, by Revenue in 2021
3.5 Global Companies Lungs in Vitro Model Product Type
3.6 Tier 1, Tier 2 and Tier 3 Lungs in Vitro Model Players in Global Market
  3.6.1 List of Global Tier 1 Lungs in Vitro Model Companies
  3.6.2 List of Global Tier 2 and Tier 3 Lungs in Vitro Model Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Lungs in Vitro Model Market Size Markets, 2021 & 2028
  4.1.2 2D Cell Models
  4.1.3 3D Cell Models
4.2 By Type - Global Lungs in Vitro Model Revenue & Forecasts
  4.2.1 By Type - Global Lungs in Vitro Model Revenue, 2017-2022
  4.2.2 By Type - Global Lungs in Vitro Model Revenue, 2023-2028
  4.2.3 By Type - Global Lungs in Vitro Model Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Lungs in Vitro Model Market Size, 2021 & 2028
  5.1.2 Drug Discovery and Toxicology
  5.1.3 3D Model Development
  5.1.4 Basic Research
  5.1.5 Physiological Research
  5.1.6 Stem Cell Research and Regenerative Medicine
5.2 By Application - Global Lungs in Vitro Model Revenue & Forecasts
  5.2.1 By Application - Global Lungs in Vitro Model Revenue, 2017-2022
  5.2.2 By Application - Global Lungs in Vitro Model Revenue, 2023-2028
  5.2.3 By Application - Global Lungs in Vitro Model Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Lungs in Vitro Model Market Size, 2021 & 2028
6.2 By Region - Global Lungs in Vitro Model Revenue & Forecasts
  6.2.1 By Region - Global Lungs in Vitro Model Revenue, 2017-2022
  6.2.2 By Region - Global Lungs in Vitro Model Revenue, 2023-2028
  6.2.3 By Region - Global Lungs in Vitro Model Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Lungs in Vitro Model Revenue, 2017-2028
  6.3.2 US Lungs in Vitro Model Market Size, 2017-2028
  6.3.3 Canada Lungs in Vitro Model Market Size, 2017-2028
  6.3.4 Mexico Lungs in Vitro Model Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Lungs in Vitro Model Revenue, 2017-2028
  6.4.2 Germany Lungs in Vitro Model Market Size, 2017-2028
  6.4.3 France Lungs in Vitro Model Market Size, 2017-2028
  6.4.4 U.K. Lungs in Vitro Model Market Size, 2017-2028
  6.4.5 Italy Lungs in Vitro Model Market Size, 2017-2028
  6.4.6 Russia Lungs in Vitro Model Market Size, 2017-2028
  6.4.7 Nordic Countries Lungs in Vitro Model Market Size, 2017-2028
  6.4.8 Benelux Lungs in Vitro Model Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Lungs in Vitro Model Revenue, 2017-2028
  6.5.2 China Lungs in Vitro Model Market Size, 2017-2028
  6.5.3 Japan Lungs in Vitro Model Market Size, 2017-2028
  6.5.4 South Korea Lungs in Vitro Model Market Size, 2017-2028
  6.5.5 Southeast Asia Lungs in Vitro Model Market Size, 2017-2028
  6.5.6 India Lungs in Vitro Model Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Lungs in Vitro Model Revenue, 2017-2028
  6.6.2 Brazil Lungs in Vitro Model Market Size, 2017-2028
  6.6.3 Argentina Lungs in Vitro Model Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Lungs in Vitro Model Revenue, 2017-2028
  6.7.2 Turkey Lungs in Vitro Model Market Size, 2017-2028
  6.7.3 Israel Lungs in Vitro Model Market Size, 2017-2028
  6.7.4 Saudi Arabia Lungs in Vitro Model Market Size, 2017-2028
  6.7.5 UAE Lungs in Vitro Model Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 ATCC
  7.1.1 ATCC Corporate Summary
  7.1.2 ATCC Business Overview
  7.1.3 ATCC Lungs in Vitro Model Major Product Offerings
  7.1.4 ATCC Lungs in Vitro Model Revenue in Global Market (2017-2022)
  7.1.5 ATCC Key News
7.2 Lonza
  7.2.1 Lonza Corporate Summary
  7.2.2 Lonza Business Overview
  7.2.3 Lonza Lungs in Vitro Model Major Product Offerings
  7.2.4 Lonza Lungs in Vitro Model Revenue in Global Market (2017-2022)
  7.2.5 Lonza Key News
7.3 Epithelix
  7.3.1 Epithelix Corporate Summary
  7.3.2 Epithelix Business Overview
  7.3.3 Epithelix Lungs in Vitro Model Major Product Offerings
  7.3.4 Epithelix Lungs in Vitro Model Revenue in Global Market (2017-2022)
  7.3.5 Epithelix Key News
7.4 Mattek
  7.4.1 Mattek Corporate Summary
  7.4.2 Mattek Business Overview
  7.4.3 Mattek Lungs in Vitro Model Major Product Offerings
  7.4.4 Mattek Lungs in Vitro Model Revenue in Global Market (2017-2022)
  7.4.5 Mattek Key News
7.5 Emulate
  7.5.1 Emulate Corporate Summary
  7.5.2 Emulate Business Overview
  7.5.3 Emulate Lungs in Vitro Model Major Product Offerings
  7.5.4 Emulate Lungs in Vitro Model Revenue in Global Market (2017-2022)
  7.5.5 Emulate Key News
7.6 Mimetas
  7.6.1 Mimetas Corporate Summary
  7.6.2 Mimetas Business Overview
  7.6.3 Mimetas Lungs in Vitro Model Major Product Offerings
  7.6.4 Mimetas Lungs in Vitro Model Revenue in Global Market (2017-2022)
  7.6.5 Mimetas Key News
7.7 Tissuse
  7.7.1 Tissuse Corporate Summary
  7.7.2 Tissuse Business Overview
  7.7.3 Tissuse Lungs in Vitro Model Major Product Offerings
  7.7.4 Tissuse Lungs in Vitro Model Revenue in Global Market (2017-2022)
  7.7.5 Tissuse Key News
7.8 Insphero
  7.8.1 Insphero Corporate Summary
  7.8.2 Insphero Business Overview
  7.8.3 Insphero Lungs in Vitro Model Major Product Offerings
  7.8.4 Insphero Lungs in Vitro Model Revenue in Global Market (2017-2022)
  7.8.5 Insphero Key News
7.9 Cn Bio
  7.9.1 Cn Bio Corporate Summary
  7.9.2 Cn Bio Business Overview
  7.9.3 Cn Bio Lungs in Vitro Model Major Product Offerings
  7.9.4 Cn Bio Lungs in Vitro Model Revenue in Global Market (2017-2022)
  7.9.5 Cn Bio Key News
7.10 AlveoliX
  7.10.1 AlveoliX Corporate Summary
  7.10.2 AlveoliX Business Overview
  7.10.3 AlveoliX Lungs in Vitro Model Major Product Offerings
  7.10.4 AlveoliX Lungs in Vitro Model Revenue in Global Market (2017-2022)
  7.10.5 AlveoliX Key News
7.11 Oncotheis
  7.11.1 Oncotheis Corporate Summary
  7.11.2 Oncotheis Business Overview
  7.11.3 Oncotheis Lungs in Vitro Model Major Product Offerings
  7.11.4 Oncotheis Lungs in Vitro Model Revenue in Global Market (2017-2022)
  7.11.5 Oncotheis Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Lungs in Vitro Model Market Opportunities & Trends in Global Market
Table 2. Lungs in Vitro Model Market Drivers in Global Market
Table 3. Lungs in Vitro Model Market Restraints in Global Market
Table 4. Key Players of Lungs in Vitro Model in Global Market
Table 5. Top Lungs in Vitro Model Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Lungs in Vitro Model Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Lungs in Vitro Model Revenue Share by Companies, 2017-2022
Table 8. Global Companies Lungs in Vitro Model Product Type
Table 9. List of Global Tier 1 Lungs in Vitro Model Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Lungs in Vitro Model Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Lungs in Vitro Model Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Lungs in Vitro Model Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Lungs in Vitro Model Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Lungs in Vitro Model Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Lungs in Vitro Model Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Lungs in Vitro Model Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Lungs in Vitro Model Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Lungs in Vitro Model Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Lungs in Vitro Model Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Lungs in Vitro Model Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Lungs in Vitro Model Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Lungs in Vitro Model Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Lungs in Vitro Model Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Lungs in Vitro Model Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Lungs in Vitro Model Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Lungs in Vitro Model Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Lungs in Vitro Model Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Lungs in Vitro Model Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Lungs in Vitro Model Revenue, (US$, Mn), 2023-2028
Table 30. ATCC Corporate Summary
Table 31. ATCC Lungs in Vitro Model Product Offerings
Table 32. ATCC Lungs in Vitro Model Revenue (US$, Mn), (2017-2022)
Table 33. Lonza Corporate Summary
Table 34. Lonza Lungs in Vitro Model Product Offerings
Table 35. Lonza Lungs in Vitro Model Revenue (US$, Mn), (2017-2022)
Table 36. Epithelix Corporate Summary
Table 37. Epithelix Lungs in Vitro Model Product Offerings
Table 38. Epithelix Lungs in Vitro Model Revenue (US$, Mn), (2017-2022)
Table 39. Mattek Corporate Summary
Table 40. Mattek Lungs in Vitro Model Product Offerings
Table 41. Mattek Lungs in Vitro Model Revenue (US$, Mn), (2017-2022)
Table 42. Emulate Corporate Summary
Table 43. Emulate Lungs in Vitro Model Product Offerings
Table 44. Emulate Lungs in Vitro Model Revenue (US$, Mn), (2017-2022)
Table 45. Mimetas Corporate Summary
Table 46. Mimetas Lungs in Vitro Model Product Offerings
Table 47. Mimetas Lungs in Vitro Model Revenue (US$, Mn), (2017-2022)
Table 48. Tissuse Corporate Summary
Table 49. Tissuse Lungs in Vitro Model Product Offerings
Table 50. Tissuse Lungs in Vitro Model Revenue (US$, Mn), (2017-2022)
Table 51. Insphero Corporate Summary
Table 52. Insphero Lungs in Vitro Model Product Offerings
Table 53. Insphero Lungs in Vitro Model Revenue (US$, Mn), (2017-2022)
Table 54. Cn Bio Corporate Summary
Table 55. Cn Bio Lungs in Vitro Model Product Offerings
Table 56. Cn Bio Lungs in Vitro Model Revenue (US$, Mn), (2017-2022)
Table 57. AlveoliX Corporate Summary
Table 58. AlveoliX Lungs in Vitro Model Product Offerings
Table 59. AlveoliX Lungs in Vitro Model Revenue (US$, Mn), (2017-2022)
Table 60. Oncotheis Corporate Summary
Table 61. Oncotheis Lungs in Vitro Model Product Offerings
Table 62. Oncotheis Lungs in Vitro Model Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Lungs in Vitro Model Segment by Type in 2021
Figure 2. Lungs in Vitro Model Segment by Application in 2021
Figure 3. Global Lungs in Vitro Model Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Lungs in Vitro Model Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Lungs in Vitro Model Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Lungs in Vitro Model Revenue in 2021
Figure 8. By Type - Global Lungs in Vitro Model Revenue Market Share, 2017-2028
Figure 9. By Application - Global Lungs in Vitro Model Revenue Market Share, 2017-2028
Figure 10. By Region - Global Lungs in Vitro Model Revenue Market Share, 2017-2028
Figure 11. By Country - North America Lungs in Vitro Model Revenue Market Share, 2017-2028
Figure 12. US Lungs in Vitro Model Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Lungs in Vitro Model Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Lungs in Vitro Model Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Lungs in Vitro Model Revenue Market Share, 2017-2028
Figure 16. Germany Lungs in Vitro Model Revenue, (US$, Mn), 2017-2028
Figure 17. France Lungs in Vitro Model Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Lungs in Vitro Model Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Lungs in Vitro Model Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Lungs in Vitro Model Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Lungs in Vitro Model Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Lungs in Vitro Model Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Lungs in Vitro Model Revenue Market Share, 2017-2028
Figure 24. China Lungs in Vitro Model Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Lungs in Vitro Model Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Lungs in Vitro Model Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Lungs in Vitro Model Revenue, (US$, Mn), 2017-2028
Figure 28. India Lungs in Vitro Model Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Lungs in Vitro Model Revenue Market Share, 2017-2028
Figure 30. Brazil Lungs in Vitro Model Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Lungs in Vitro Model Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Lungs in Vitro Model Revenue Market Share, 2017-2028
Figure 33. Turkey Lungs in Vitro Model Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Lungs in Vitro Model Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Lungs in Vitro Model Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Lungs in Vitro Model Revenue, (US$, Mn), 2017-2028
Figure 37. ATCC Lungs in Vitro Model Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Lonza Lungs in Vitro Model Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Epithelix Lungs in Vitro Model Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Mattek Lungs in Vitro Model Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Emulate Lungs in Vitro Model Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Mimetas Lungs in Vitro Model Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Tissuse Lungs in Vitro Model Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Insphero Lungs in Vitro Model Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Cn Bio Lungs in Vitro Model Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. AlveoliX Lungs in Vitro Model Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Oncotheis Lungs in Vitro Model Revenue Year Over Year Growth (US$, Mn) & (2017-2022)